Summary
I am Senior Clinical Research Fellow in vaccinology and Honorary Consultant in genitourinary medicine at Imperial College London and Imperial College Healthcare NHS Trust. I read medicine at Newnham College, University of Cambridge, and Imperial College London before completing speciality training as a clinician scientist in genitourinary medicine and immunology. My research investigates diversity in T cell responses to accelerate discovery in vaccine design and implementation. I lead first-in-human trials and experimental medicine studies of novel vaccines against hard-to-target pathogens including HIV and chlamydia. I am Chief and Principal Investigator for the Imperial College London self amplifying RNA SARS-CoV-2 vaccine and Oxford Astra-Zeneca COVID-19 vaccine trials. I received a Department of Infectious Disease award for substantial and exceptional achievement during the COVID-19 pandemic.
Publications
Journals
Ogbe A, Pace M, Bittaye M, et al. , 2022, Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV., Jci Insight, Vol:7
Alexander JL, Kennedy NA, Ibraheim H, et al. , 2022, COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study, The Lancet Gastroenterology & Hepatology, Vol:7, ISSN:2468-1253, Pages:342-352
Pollock KM, Cheeseman HM, Szubert AJ, et al. , 2022, Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial, Eclinicalmedicine, Vol:44, ISSN:2589-5370
Hodgson SH, Iveson P, Larwood J, et al. , 2022, Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial, Cts-clinical and Translational Science, Vol:15, ISSN:1752-8054, Pages:524-534
Cole ME, Guo Y, Cheeseman HM, et al. , 2022, Multicolor Flow Cytometry and High-Dimensional Data Analysis to Probe Complex Questions in Vaccinology., Methods Mol Biol, Vol:2414, Pages:433-447